Free shipping on all orders over $ 500

Elafibranor

Cat. No. M9476

All AbMole products are for research use only, cannot be used for human consumption.

Elafibranor Structure
Synonym:

GFT505

Size Price Availability Quantity
1mg USD 30 In stock
5mg USD 55 In stock
10mg USD 80 In stock
25mg USD 135 In stock
50mg USD 220 In stock
100mg USD 360 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Elafibranor (also known as GFT-505) is a dual PPARα/δ agonist with EC50s of 45 and 175 nM, respectively. Elafibranor (GFT505) treatment improves glucose control and plasma lipids in diabetic db/db mice. A significant dose-dependent reduction of hepatic expression of the key gluconeogenic enzymes glucose 6-phosphatase (G6Pase), PEPCK, and fructose 1,6-bisphosphatase 1 (FBP1) is observed with Elafibranor.

Protocol (for reference only)
Cell Experiment
Cell lines
Preparation method
Concentrations
Incubation time
Animal Experiment
Animal models Male db/db and db/lean mice
Formulation 0.1% Tween 80 and 1% carboxymethylcellulose in 98.9% distilled water
Dosages 3, 10 and 30 mg/kg/day
Administration oral gavage
Chemical Information
Molecular Weight 384.49
Formula C22H24O4S
CAS Number 923978-27-2
Solubility (25°C) DMSO ≥ 33 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Ratziu V, et al. Gastroenterology. Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening.

[2] Hanf R, et al. Diab Vasc Dis Res. The dual peroxisome proliferator-activated receptor alpha/delta agonist GFT505 exerts anti-diabetic effects in db/db mice without peroxisome proliferator-activated receptor gamma-associated adverse cardiac effects.

Related PPAR Products
WY 14643 (Pirinixic Acid)

WY 14643 (Pirinixic Acid) is a potent and selective, peroxisome proliferator-activated receptor-α (PPARα) agonist.

Rosiglitazone

Rosiglitazone (BRL 49653) is an orally active selective PPARγ agonist (EC50=60 nM, Kd=40 nM). Rosiglitazone is an TRPC5 activator (EC50=30 μM) and TRPM3 inhibitor.

GSK 3787

GSK3787 is an orally available selective peroxisome proliferator-activated receptor δ (PPARδ) antagonist (pIC50 = 6.6).

Rosiglitazone maleate

Rosiglitazone maleate (Avandia) is a potent and selective PPARγ ligand that binds to the PPARγ ligand-binding domain with a Kd value of 43 nM.

Ciprofibrate

Ciprofibrate is a peroxisome proliferator-activated receptor α (PPARα) agonist.

  Catalog
Abmole Inhibitor Catalog




Keywords: Elafibranor, GFT505 supplier, PPAR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.